APYX LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - APYXPRNewsWire • 07/20/22
RENUVION® CLEARED BY FDA FOR NECK LAXITY PROCEDURES OFFERING PATIENTS A MINIMALLY INVASIVE OPTION TO ELIMINATE SAGGING NECKPRNewsWire • 07/18/22
Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Improve Appearance of Lax (Loose) SkinBusiness Wire • 07/18/22
ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important August 5 Deadline in Securities Class Action - APYXNewsfile Corp • 07/18/22
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APYXNewsfile Corp • 07/14/22
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Apyx Medical Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - APYXPRNewsWire • 07/13/22
APYX MEDICAL CORPORATION (NASDAQ: APYX) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Apyx Medical Corporation (NASDAQ: APYX)PRNewsWire • 07/09/22
Apyx Medical Corporation Announces Results of the U.S. IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental RegionBusiness Wire • 07/08/22
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - APYXNewsfile Corp • 07/07/22
APYX MEDICAL CORPORATION Company News: Berger Montague Investigates Securities Fraud Allegations Against Apyx Medical Corp. (APYX); Lead Plaintiff Deadline is August 5, 2022Newsfile Corp • 07/05/22
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Apyx Medical Corporation Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - APYXPRNewsWire • 07/02/22
ROSEN, Top Ranked Investor Counsel, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APYXNewsfile Corp • 06/30/22
APYX MEDICAL CORPORATION Company News: Berger Montague Investigates Securities Fraud Allegations Against Apyx Medical Corp. (NASDAQ: APYX); Lead Plaintiff Deadline is August 5, 2022PRNewsWire • 06/30/22
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022Business Wire • 06/30/22
Apyx Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before August 5, 2022 to Discuss Your Rights - APYXNewsfile Corp • 06/28/22
APYX INVESTOR NOTICE: ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APYXNewsfile Corp • 06/27/22
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Apyx Medical Corporation - APYXNewsfile Corp • 06/25/22
ROSEN, A LEADING LAW FIRM, Encourages Apyx Medical Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - APYXPRNewsWire • 06/25/22
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action - APYXNewsfile Corp • 06/25/22
APYX LOSS ALERT: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APYXNewsfile Corp • 06/21/22
Apyx Medical Corporation Investor News: Robbins LLP is Investigating Apyx Medical Corporation (APYX) on Behalf of ShareholdersBusiness Wire • 06/18/22
Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of APYX Medical Corporation (APYX) Investors and Encourages Investors to Contact the Firm Before August 5, 2022Business Wire • 06/17/22
APYX EQUITY ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APYXPRNewsWire • 06/17/22